Julian Wolfes, Cora-Alea Colla, Gerrit Frommeyer, Christian Ellermann, Lars Eckardt
{"title":"AF-CARE in the Elderly: Implications of the 2024 ESC Guideline on the Management of Atrial Fibrillation in Older Patients.","authors":"Julian Wolfes, Cora-Alea Colla, Gerrit Frommeyer, Christian Ellermann, Lars Eckardt","doi":"10.1159/000548492","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is anticipated that demographic trends will result in a notable increase in the number of elderly and geriatric patients globally. Concurrently, atrial fibrillation exhibits a pronounced age-dependent prevalence, thereby anticipating a substantial increase in the number of elderly atrial fibrillation patients. In this context, we have examined the recently published European Society of Cardiology (ESC) guidelines on the management of atrial fibrillation from 2024, analyzing their recommendations and implications for atrial fibrillation management in elderly patients, and critically summarized the recent recommendations.</p><p><strong>Summary: </strong>In summary, it can be stated that the guideline makes age-dependent recommendations in some areas. Such recommendations can be found in particular for the indication for anticoagulation and for switching anticoagulation therapy from VKA to DOAC, or for atrial fibrillation screening. When it comes to rhythm control and catheter ablation, however, there are few age-specific recommendations and the particularities and heterogeneities of this patient group tend to be underrepresented in the guidelines.</p><p><strong>Key messages: </strong>Tailored recommendations for elderly patients can be found in the ESC guidelines on the management of atrial fibrillation for atrial fibrillation screening and anticoagulation. In particular, the recommendations on rhythm control and catheter ablation lack specific recommendations for older patients.</p>","PeriodicalId":12662,"journal":{"name":"Gerontology","volume":" ","pages":"54-62"},"PeriodicalIF":3.1000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gerontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548492","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: It is anticipated that demographic trends will result in a notable increase in the number of elderly and geriatric patients globally. Concurrently, atrial fibrillation exhibits a pronounced age-dependent prevalence, thereby anticipating a substantial increase in the number of elderly atrial fibrillation patients. In this context, we have examined the recently published European Society of Cardiology (ESC) guidelines on the management of atrial fibrillation from 2024, analyzing their recommendations and implications for atrial fibrillation management in elderly patients, and critically summarized the recent recommendations.
Summary: In summary, it can be stated that the guideline makes age-dependent recommendations in some areas. Such recommendations can be found in particular for the indication for anticoagulation and for switching anticoagulation therapy from VKA to DOAC, or for atrial fibrillation screening. When it comes to rhythm control and catheter ablation, however, there are few age-specific recommendations and the particularities and heterogeneities of this patient group tend to be underrepresented in the guidelines.
Key messages: Tailored recommendations for elderly patients can be found in the ESC guidelines on the management of atrial fibrillation for atrial fibrillation screening and anticoagulation. In particular, the recommendations on rhythm control and catheter ablation lack specific recommendations for older patients.
期刊介绍:
In view of the ever-increasing fraction of elderly people, understanding the mechanisms of aging and age-related diseases has become a matter of urgent necessity. ''Gerontology'', the oldest journal in the field, responds to this need by drawing topical contributions from multiple disciplines to support the fundamental goals of extending active life and enhancing its quality. The range of papers is classified into four sections. In the Clinical Section, the aetiology, pathogenesis, prevention and treatment of agerelated diseases are discussed from a gerontological rather than a geriatric viewpoint. The Experimental Section contains up-to-date contributions from basic gerontological research. Papers dealing with behavioural development and related topics are placed in the Behavioural Science Section. Basic aspects of regeneration in different experimental biological systems as well as in the context of medical applications are dealt with in a special section that also contains information on technological advances for the elderly. Providing a primary source of high-quality papers covering all aspects of aging in humans and animals, ''Gerontology'' serves as an ideal information tool for all readers interested in the topic of aging from a broad perspective.